NCT03297723 2025-10-06
EFFADOL-K
Centre Francois Baclesse
Completed
Clinical Trials
23 trialsNCT05493150 2025-09-08
Well Being
Centre Hospitalier de Valence
Completed
NCT06777004 2025-01-15
CIBP
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Completed
NCT04595032 2024-11-07
MAMETIC
National Cancer Institute, Naples
Completed
NCT05265442 2024-10-31
DUNE
RECORDATI GROUP
Completed
NCT04219072 2024-10-15
Clinical Classification of Pain in Breast Cancer Survivors
Kutahya Health Sciences University
Completed
NCT06369961 2024-04-17
Correlation Between the Analgesic Effect of Fentanyl Transdermal Patches and Nutritional Status in Cancer Pain Patients
Chongqing University Cancer Hospital
Completed
NCT03981809 2023-08-22
PainsCan
Universitaire Ziekenhuizen KU Leuven
Completed
NCT04938440 2023-08-01
Assessment of Updated Educational Materials for Instanyl®
Takeda
Completed
NCT04537845 2022-09-21
Retrospective Analysis of PET Brain Imaging in Chronic Cancer Pain
National Taiwan University Hospital
Completed
NCT05209906 2022-08-23
An Observation Study to Assess the Efficacy and Safety of Proportional Doses of Painkyl® in Patients With Breakthrough Cancer Pain
Mackay Memorial Hospital
Completed
NCT04491123 2020-07-29
IT-ESAS
University Hospital, Montpellier
Completed
NCT04404933 2020-05-28
StOIC-2
Royal Surrey County Hospital NHS Foundation Trust
Completed
NCT04350112 2020-04-16
StOIC-1
Royal Surrey County Hospital NHS Foundation Trust
Completed
NCT03727373 2020-03-27
QualiPain
University Hospital Schleswig-Holstein
Completed
NCT04315831 2020-03-20
SOOTHE
Taiwan Mundipharma Pharmaceuticals Ltd.
Completed
NCT01946555 2016-04-14
RER
Mario Negri Institute for Pharmacological Research
Completed
NCT02293785 2016-03-21
GREAT - Good Response With Appropriate Treatment
Mario Negri Institute for Pharmacological Research
Completed
NCT02341846 2016-01-21
Exploring New Technologies to Manage Cancer Pain in the Community
University of Aberdeen
Completed
NCT01532895 2014-03-18
Clinical Usefulness and Quality of Life of OROS Hydromorphone in Patients Who Have Not Been Treated With a Strong Opioid
Janssen Korea, Ltd., Korea
Completed
NCT01816503 2013-03-22
Fentanyl Matrix Application for Cancer Pain: Multicenter, Prospective, Observational Study
Janssen Korea, Ltd., Korea
Completed
NCT01402830 2013-02-11
Case-control Study- Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients (Fentanyl)
Janssen-Cilag, S.A.
Completed
NCT01230515 2012-09-10
Opioid Titration in the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and Protocol
Vanderbilt-Ingram Cancer Center
Completed